Valuation: Bionano Genomics, Inc.

Market Cap 20.37M 17.77M 16.78M 15.23M 28.54M 1.96B 28.66M 201M 77.55M 994M 76.54M 74.84M 3.2B P/E 2026 *
-0.81x
P/E 2027 * -1.78x
Enterprise Value 20.37M 17.77M 16.78M 15.23M 28.54M 1.96B 28.66M 201M 77.55M 994M 76.54M 74.84M 3.2B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 0.47x
Free-Float
92.78%
Yield 2026 *
-
Yield 2027 * -
1 day-0.57%
1 week+41.80%
Current month+41.80%
1 month+40.65%
3 months+51.75%
6 months+54.46%
Current year+13.07%
1 week 1.21
Extreme 1.2143
2.23
1 month 1.15
Extreme 1.15
2.23
Current year 1
Extreme 1
2.23
1 year 1
Extreme 1
2.23
3 years 1
Extreme 1
187.69
5 years 1
Extreme 1
3,767.39
10 years 1
Extreme 1
9,413.98
Manager TitleAgeSince
Chief Executive Officer 77 2026-05-04
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 52 2014-09-30
Director TitleAgeSince
Chairman 84 2016-09-07
Chairman 77 2024-05-31
Director/Board Member 66 2018-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Buy

Chief Executive Officer

4,000 0.0340%
8/21/26 Buy

Chief Executive Officer

4,000 0.0349%
8/3/26 Free

Controller/Auditor

5,000 0.0436%
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%+41.80%-3.35%-99.04% 20.37M
-1.04%+6.83%+35.84%+28.05% 241B
-0.32%+5.83%+9.58%-17.01% 149B
+2.55%+6.55%-10.35%+31.26% 139B
-0.48%+0.84%-55.70%-18.27% 62.81B
+0.01%+4.61%+18.61%+20.87% 50.87B
-1.69%-1.20%-19.89%-15.39% 48.21B
+0.08%+6.49%+23.87%+39.32% 44.11B
-1.88%+3.25%+40.14%+53.16% 41.42B
-2.27%+16.07%+133.21%+70.51% 36.18B
Average -0.56%+9.96%+17.20%+9.35% 81.24B
Weighted average by Cap. -0.26%+6.14%+15.57%+17.51%

Financials

2026 *2027 *
Net sales 32.14M 28.02M 26.46M 24.03M 45.02M 3.08B 45.21M 317M 122M 1.57B 121M 118M 5.04B 43.3M 37.76M 35.65M 32.37M 60.66M 4.15B 60.91M 427M 165M 2.11B 163M 159M 6.8B
Net income -29.31M -25.56M -24.14M -21.92M -41.06M -2.81B -41.24M -289M -112M -1.43B -110M -108M -4.6B -23.04M -20.09M -18.97M -17.23M -32.27M -2.21B -32.41M -227M -87.68M -1.12B -86.54M -84.62M -3.62B
Net Debt - -
Logo Bionano Genomics, Inc.
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Employees
96
Date Price Change Volume
26-09-18 US$1.730 -0.57% 1,197,986
26-09-17 US$1.740 +15.23% 2,504,077
26-09-16 US$1.510 -3.21% 1,865,942
26-09-15 US$1.560 +17.29% 39,778,663
26-09-14 US$1.330 +9.02% 409,550
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.730USD
Average target price
5.000USD
Spread / Average Target
+189.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNGO Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!